147 related articles for article (PubMed ID: 12378880)
1. [Catecholamine metabolism in different forms of Parkinson's disease].
Selikhova MV; Kogan BM; Serkin GV; Gusev EI
Zh Nevrol Psikhiatr Im S S Korsakova; 2002; 102(9):37-40. PubMed ID: 12378880
[TBL] [Abstract][Full Text] [Related]
2. Catecholamines and their metabolites in the brain and urine of rats with experimental Parkinson's disease.
Chekhonin VP; Baklaushev VP; Kogan BM; Savchenko EA; Lebedev SV; Man'kovskaya IV; Filatova TS; Yusupova IU; Dmitrieva TB
Bull Exp Biol Med; 2000 Aug; 130(8):805-9. PubMed ID: 11177250
[TBL] [Abstract][Full Text] [Related]
3. Dopa, catecholamines and their metabolites in essential hypertension.
Januszewicz W; Wocial B
Clin Sci Mol Med Suppl; 1975 Jun; 2():295s-298s. PubMed ID: 1077780
[TBL] [Abstract][Full Text] [Related]
4. Excretion of L-dopa and its metabolites in urine of Parkinson's disease patients receiving L-dopa therapy.
Routh JI; Bannow RE; Fincham RW; Stoll JL
Clin Chem; 1971 Sep; 17(9):867-71. PubMed ID: 5571485
[No Abstract] [Full Text] [Related]
5. Study of some biological indices of the state of the sympathoadrenaline system under the effect of polychlorocamphene.
Kuz'minskaya UA; Ivanitskiĭ VA
Environ Health Perspect; 1979 Jun; 30():91-5. PubMed ID: 446464
[TBL] [Abstract][Full Text] [Related]
6. [Determination of free and conjugated catecholamines, 3,4-dihydroxyphenylalanine, 3,4-dihydroxyphenylacetic acid in the urine and blood plasma by high pressure liquid chromatography].
Kogan BM; Drozdov AZ; Man'kovskaia IV; Filatova TS
Klin Lab Diagn; 1995; (3):25-8. PubMed ID: 8689050
[TBL] [Abstract][Full Text] [Related]
7. [Catecholamines metabolism in extrapyramidal disorders in children].
Mosunova TG
Zh Nevropatol Psikhiatr Im S S Korsakova; 1977; 77(10):1466-9. PubMed ID: 930491
[TBL] [Abstract][Full Text] [Related]
8. [Modifications of catecholamine metabolism under the effect of a decarboxylase inhibitor associated with L-dopa and desipramine in patients with depressive and parkinsonian syndromes].
Geissbuhler F; Bartholini G; Gaillard JM; Tissot R
Encephale; 1971; 60(3):189-209. PubMed ID: 5119348
[No Abstract] [Full Text] [Related]
9. [Catecholamine metabolism in Parkinson's disease with depression].
Selikhova MV; Kogan BM; Ustinova IL
Zh Nevrol Psikhiatr Im S S Korsakova; 2003; 103(1):39-42. PubMed ID: 12616737
[TBL] [Abstract][Full Text] [Related]
10. [Catecholamine excretion and treatment of parkinsonism with midantan].
Kandel' EI; Iadgarov IS
Zh Nevropatol Psikhiatr Im S S Korsakova; 1976 Sep; 76(9):1323-6. PubMed ID: 1015136
[No Abstract] [Full Text] [Related]
11. The biochemistry of catecholamines in relation to Parkinson's disease.
Hinterberger H
Aust N Z J Med; 1971 May; 1():Suppl 1:14-8. PubMed ID: 5292808
[No Abstract] [Full Text] [Related]
12. Parkinson's disease: the effect of L-dopa therapy on urinary free catecholamines and metabolites.
Davidson DF; Grosset K; Grosset D
Ann Clin Biochem; 2007 Jul; 44(Pt 4):364-8. PubMed ID: 17594783
[TBL] [Abstract][Full Text] [Related]
13. [L-DOPA test for evaluating in vivo catecholamine biosynthesis in normal persons and persons with different diseases].
Vasil'ev VN; Matlina ESh
Vopr Med Khim; 1977; (3):332-8. PubMed ID: 888397
[TBL] [Abstract][Full Text] [Related]
14. Rapid procedure for chromatographic isolation of DOPA, DOPAC, epinephrine, norepinephrine and dopamine from a single urinary sample at endogenous levels.
Dalmaz Y; Peyrin L
J Chromatogr; 1978 Jan; 145(1):11-27. PubMed ID: 621235
[TBL] [Abstract][Full Text] [Related]
15. [Catecholamine excretion in torsion dystonia].
Barkatova VP
Zh Nevropatol Psikhiatr Im S S Korsakova; 1978; 78(4):495-503. PubMed ID: 654723
[TBL] [Abstract][Full Text] [Related]
16. [Catecholamine metabolism in manic-depressive psychosis].
Usherenko LS
Fiziol Zh; 1970; 16(3):393-9. PubMed ID: 5509683
[No Abstract] [Full Text] [Related]
17. [Effect of a test with 0.1 g of L-DOPA on the dynamics of urinary excretion of catecholamines and DOPA in schizophrenic patients].
Vasil'ev VN
Vopr Med Khim; 1980; 26(6):782-6. PubMed ID: 6779421
[TBL] [Abstract][Full Text] [Related]
18. [Catecholamine and DOPA excretion in peptic ulcer patients].
Frenkel' ID
Vopr Med Khim; 1973; 19(5):518-23. PubMed ID: 4788178
[No Abstract] [Full Text] [Related]
19. [The effect of alpha-DOPA on the dynamics of urinary excretion of DOPA, catecholamines and their metabolites in healthy subjects and in patients with parkinsonism].
Matlina ESh; Kandel' EI; Vasil'ev VN; Iadgarov IS; Bol'shakova TD
Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(2):205-9. PubMed ID: 4743269
[No Abstract] [Full Text] [Related]
20. [Excretion of catecholamines and DOPA in the urine of patients with pulmonary tuberculosis during chemotherapy].
Prosvetov IuV
Probl Tuberk; 1989; (10):46-9. PubMed ID: 2512573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
